BREAKING NEWS Mike Lindell lawyers caught making cringeworthy mistake...as tycoon makes shocking Texas floods gaffe
Two lawyers representing Lindell in his defamation case over his 2020 election conspiracies are facing $3,000 fines each for submitting inaccurate briefs in April, according to KDVR.
US District Court Judge Nina Y. Wang found that attorneys Christopher I. Kachouroff and Jennifer T. DeMaster violated court rules when they submitted a motion that contained numerous errors, including misquotes from caselaw and citations to nonexistent cases, reported The Denver Post.
In June, a jury found that Lindell defamed a former employee of a prominent voting equipment company by calling him a traitor and was ordered to pay $2.3 million in damages.
His attorney's fines come as the MyPillow CEO suggested people should purchase his pillows instead of donating directly to the victims of the devastating Texas floods.
'You guys, we're helping out the flood victims here in Samaritan's Purse. So just know that part of your money goes to help them because we do that. MyPillow does that for all the tragedies across this country,' he said on Monday's episode of Steven Bannon's War Room.
'We're there for that, for that to help. And you guys have helped MyPillow. So it's a win-win-win.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
6 minutes ago
- Reuters
Trading Day: No tariff clarity, or market movement
July 8 - TRADING DAY - Making sense of the forces driving global markets By Alden Bentley, Editor in Charge, Americas Finance and Markets Jamie is enjoying some well-deserved time off, but the Reuters markets team will still keep you up to date on what markets were focused on today and why they took a breather. I'd love to hear from you so please feel free to reach out at opens new tab Today's Key Market Moves Today's Key Reads From 'fantastic' to 'spoiled': How Japan's trade effort to woo Trump backfired Gold ETFs drew largest inflow in five years during first half of 2025, WGC say In the Fed's hunt for a reason to cut rates, surveys and tariffs make answers elusive Investors put 'Liberation Day' lessons to work, scarred by tariff tumult Trump says steep copper tariffs in store as he broadens his trade war No tariff clarity, or market movement Investors let the fluid tariff situation simmer on Tuesday, sitting on their hands a day after knocking stock indexes back from record highs as U.S. President Donald Trump warned that new levies would hit a range of trading partners, including Japan and Korea. While Wall Street was in sideways mode seemingly fatigued by tariff headlines, the beaten down dollar posted the second of back-to-back gains and Treasury yields ticked higher for the fifth day running. The new date to watch is August 1 with Trump showing again his eagerness to allow time to reach deals by pushing back the deadline, which had been Wednesday since he postponed April's ill-received opening tariff gambit. In the meantime the market will stay ready for surprising turns from the White House and otherwise be waiting for economic data, the Federal Reserve and other known unknowns to incentivize trade. No major indicators are on the calendar this week, and the only set pieces to look for Wednesday are the auction of $39 billion of 10-year notes, the Treasury's benchmark U.S. debt instrument, and the release of minutes from the Fed's last meeting when they held the policy rate at 4.25%-4.5%, where it has been since December. Futures show investors expect cuts beginning in September. Last week, we saw the unemployment rate fell in June, while inflation has ticked up, also the wrong direction for easing soon. The June transcript won't reveal policymakers in great discord. They weren't very divided in their economic projections, with 10 seeing several cuts this year and nine effectively pushing easier monetary policy into 2026. Powell has insisted that any cuts will depend on the data. Meanwhile, the market will wait for the numbers and probably take the minutes in stride too. What could move markets tomorrow? Opinions expressed are those of the author. They do not reflect the views of Reuters News, which, under the Trust Principles, opens new tab, is committed to integrity, independence, and freedom from bias. Trading Day is also sent by email every weekday morning. Think your friend or colleague should know about us? Forward this newsletter to them. They can also sign up here.
Reuters
7 minutes ago
- Reuters
J&J defeats generic drugmakers in US appeal over schizophrenia treatment
July 8 (Reuters) - Johnson & Johnson (JNJ.N), opens new tab convinced a U.S. appeals court on Tuesday to reject a bid from generic drugmakers Teva ( opens new tab and Viatris (VTRS.O), opens new tab to invalidate a patent covering its schizophrenia medication Invega Sustenna. The U.S. Court of Appeals for the Federal Circuit ruled that Teva and Viatris failed to demonstrate, opens new tab that the patent's innovations were obvious, blocking their path to manufacturing a cheaper generic version of J&J's blockbuster drug. In an earlier appeal in the same case last year, the Federal Circuit had granted the drugmakers' request for U.S. District Judge Claire Cecchi in New Jersey to reconsider their case. The appeals court on Tuesday affirmed a December ruling by Cecchi that J&J's patent was valid. Spokespeople for Teva and Viatris did not immediately respond to requests for comment on the decision. A J&J spokesperson said that the company was pleased with the ruling. J&J sold more than $4.2 billion worth of Invega Sustenna and related drugs worldwide last year, with more than $3.1 billion in U.S. sales, according to a company report. It sued Teva and Mylan, which is now part of Viatris, for patent infringement over their proposed generic versions of the drug in 2018 and 2019, respectively. Cecchi ruled in 2021 that Teva failed to prove a J&J patent covering a dosing regimen for Invega Sustenna was invalid. Viatris agreed to be bound by Cecchi's decision. The Federal Circuit overturned that ruling last April and remanded the case to New Jersey. The appeals court gave Teva another chance to prove that the patent was invalid by showing that the dosing regimen would have been obvious to an ordinary person in the field. Cecchi ruled for J&J again in December. The appeals court upheld the decision on Tuesday, agreeing with the judge that the dosing regimen was not obvious. The case is Janssen Pharmaceuticals Inc v. Teva Pharmaceuticals USA Inc, U.S. Court of Appeals for the Federal Circuit, No. 2025-1228. For J&J: Barbara Mullin of Patterson Belknap Webb & Tyler For Teva and Mylan: John O'Quinn of Kirkland & Ellis For Mylan: Deepro Mukerjee of Katten Muchin Rosenman Read more: Teva, Viatris win new chance to challenge J&J schizophrenia drug patent
Telegraph
13 minutes ago
- Telegraph
Amazon withdraws ‘error-strewn' biographies of SNP politicians
The online retailer Amazon has removed unofficial biographies of high-profile SNP politicians from sale that were allegedly strewn with errors. The books, which appeared to have been created using AI, included two on First Minister John Swinney and his predecessor Nicola Sturgeon that were taken down from the site after The Times newspaper reported they contained several false claims. Four more unofficial biographies of Ms Sturgeon and Humza Yousaf, another former first minister, were listed as unavailable on Monday after the BBC asked Amazon about the titles. The firm said it removed books that violated its content guidelines. The Times reported that a book about Mr Swinney – called John Swinney Biography: John Swinney: Scotland's Education Architect – falsely claimed the first minister was born in the US to a Polish mother. The newspaper also highlighted several inaccuracies in other books about Ms Sturgeon and Mr Yousaf's families. The books about Mr Yousaf, who was privately educated, repeatedly suggested he had grown up in poverty. One claimed to be an 'exposé' of a police investigation into SNP finances. According to the book description on Amazon, it was written by 'renowned author' Brian B. Porter, who was said to have told the story of Ms Sturgeon and the SNP with 'expert storytelling and meticulous research'. It was the only book of the four to have been reviewed. It had an average rating of 1.3 out of five stars, with disappointed readers describing it as 'terrible' and lacking 'any detail or substance'. Brian B. Porter is named as the author on several other books listed on Amazon – including titles on Silvio Berlusconi, the late Italian former prime minister, the late songwriter Burt Bacharach and Bobby Hull, a Canadian ice-hockey player. An Amazon spokesman said: 'We have content guidelines governing which books can be listed for sale, and we have proactive and reactive methods that help us detect content that violates our guidelines, whether AI -generated or not. 'We invest significant time and resources to ensure our guidelines are followed, and remove books that do not adhere to those guidelines.' Both the Scottish and UK governments have spoken of the positive impact AI technology could have on efforts to improve public services However, writers and publishers have expressed fears about the impact of generative AI programmes, such as ChatGPT, on the creation of new literature and books.
